作者:
主题词
前列地尔(Alprostadil);血管成形术, 气囊(Angioplasty, Balloon);动物(Animals);消炎药(Anti-Inflammatory Agents);主动脉, 腹(Aorta, Abdominal);主动脉疾病(Aortic Diseases);动脉粥样硬化(Atherosclerosis);心血管药物(Cardiovascular Agents);趋化因子CCL2(Chemokine CCL2);胆固醇, 膳食(Cholesterol, Dietary);细胞因子类(Cytokines);疾病模型, 动物(Disease Models, Animal);疾病恶化(Disease Progression);剂量效应关系, 药物(Dose-Response Relationship, Drug);减量调节(Down-Regulation);纤维化(Fibrosis);组胺(Histamine);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);炎症介导素类(Inflammation Mediators);脂类代谢(Lipid Metabolism);巨噬细胞(Macrophages);男(雄)性(Male);基质金属蛋白酶1(Matrix Metalloproteinase 1);基质金属蛋白酶9(Matrix Metalloproteinase 9);斑块, 动脉粥样硬化(Plaque, Atherosclerotic);RNA, 信使(RNA, Messenger);兔(Rabbits);斯伐他汀(Simvastatin);蝰蛇毒液类(Viper Venoms)
DOI
10.1139/y11-115
PMID
22309388
发布时间
2023-12-13
- 浏览171
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文